Navigation Links
Research-Based Biopharmaceutical Company Awards Trials to DATATRAK
Date:8/25/2009

s to meet customer and market needs; fluctuations in the Company's quarterly results; the viability of the Company's business strategy and its early stage of development; the timing of clinical trial sponsor decisions to conduct new clinical trials or cancel or delay ongoing trials; the Company's dependence on major customers; government regulation associated with clinical trials and the approval of new drugs; the ability of the Company to compete in the emerging EDC market; losses that potentially could be incurred from breaches of contracts or loss of customer data; the inability to protect intellectual property rights or the infringement upon other's intellectual property rights; the costs associated with maintaining and/or developing two product suites; and general economic conditions such as the rate of employment, inflation, interest rates and the condition of capital markets. This list of factors is not all-inclusive. In addition, the Company's success depends on the outcome of various strategic initiatives it has undertaken, all of which are based on assumptions made by the Company concerning trends in the clinical research market and the health care industry. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE DATATRAK International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial
2. Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
3. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
4. Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
5. Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401s Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
6. Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company Octapharma
7. XTL Biopharmaceuticals Announces the Acquisition of the Use Patent on Recombinant Erythropoietin (rHuEPO) for the Treatment of Multiple Myeloma
8. R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges
9. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
10. Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B
11. Keryx Biopharmaceuticals, Inc. Reports Phase 1/2 Data on KRX-0401 (Perifosine) at 50th Annual Meeting of American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... -- Today, UBM China, a wholly owned subsidiary of ... Exhibition Co., Ltd. to jointly run the Health Expo ... concurrently with CWMEE 2016. This cooperation ... MEDTEC China and DENTECH China, and fills its blank ... also another concrete cooperative project in Chengdu ...
(Date:6/30/2015)... 2015  July 4 th is this weekend, a ... spirit and people behind it. To help honor our current ... USA Medical Card, a leading provider of ... that empower independence for our disabled military veterans, police, firemen, ... afford their prescriptions. "Due to USA ...
(Date:6/30/2015)... N.C. , June 30, 2015  Marken, the ... to the life sciences industry, has been granted permission ... patient shipment of clinical drug product in Korea.  This ... South Korea to continue receiving their clinical ... System (MERS). The emergency was caused by ...
Breaking Medicine Technology:UBM Joins Chengdu Tianyi to Hold CWMEE 2016 2UBM Joins Chengdu Tianyi to Hold CWMEE 2016 3Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Marken Delivers Direct To Patients During MERS Outbreak 2Marken Delivers Direct To Patients During MERS Outbreak 3
... - VASTox plc (AIM: VOX), a leading,UK biotechnology ... of £400,000 by the Welsh Development Agency,(”WDA”) under ... 12 months, will support the research and development,work ... the unique skills and expertise of its scientists,based ...
... 2007 /PRNewswire-USNewswire/ -- The,following statement may be attributed ... Medical Research (CAMR): , "In the face of ... the stroke of his veto pen deliberately to ... well as endanger,the future health and well being ...
Cached Medicine Technology:Vastox Awarded £400,000 Grant to Support R&D at,Carbohydrate Chemistry Facility 2Vastox Awarded £400,000 Grant to Support R&D at,Carbohydrate Chemistry Facility 3President Bush Ignores America's Plea for Support of Stem Cell,Research 2
(Date:7/1/2015)... ... July 01, 2015 , ... Amada Senior Care, premier provider of non-medical ... greater Phoenix area – their Mesa, Arizona location . Amada franchise partners Kris ... purchase of the rights to the area after years of experience in the sales ...
(Date:7/1/2015)... ... July 01, 2015 , ... Who doesn’t want a life filled with ... a healthy balance between work and life, and positive friendships and relationships? , ... Health: Flourishing Lives, Wellbeing in Doctors. , With a focus on solving the epidemic ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... team as Director of Referral Relations. , Emily originally entered the behavioral ... she designed and implemented unique academic curriculum for clients to engage in their ...
(Date:7/1/2015)... ... July 01, 2015 , ... AvePoint, the ... opening of a new operational office in Zurich, Switzerland. The new facility will ... lines of business for organizations throughout the Swiss market. , “AvePoint is ...
(Date:7/1/2015)... ... 2015 , ... Recent research has revealed that most adults lack confidence in ... to professionals. Starting the last Monday of June, Whiter Image Dental will ... discount on the customer’s first popular In-Office 2 Patient Kit. , ...
Breaking Medicine News(10 mins):Health News:Amada Senior Care Expands to Greater Phoenix Area 2Health News:Medical Doctor Explains The Healthy Effects of a Positive Outlook in New Book 2Health News:Northbound Treatment Services Welcomes Emily Orrick as Director of Referral Relations 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 3Health News:Whiter Image Dental Offers New Customers Half-Off Teeth Whitening Kit 2
... , MONDAY, Feb. 21 (HealthDay News) -- Children with hearing loss ... to a new study. The bone-anchored hearing aid (BAHA), a ... more than 30 years ago and has become an established treatment ... children who were at least 4 years old when they underwent ...
... By Jenifer Goodwin HealthDay Reporter , MONDAY, Feb. ... linked to losses in memory and mental abilities in middle ... data on about 3,500 British men and 1,300 British women ... II, a long-term study that tracked British civil servants. ...
... Separate studies published online on February 21 in the ... identify a protein that drives tumor-promoting inflammation in pancreatic ... in several flavorsTh1 and Th2, for exampleeach classified according ... often infiltrated with cells that produce Th2 cytokines, which ...
... Feb. 21 (HealthDay News) -- Seniors who are more socially ... The study from Rush University in Chicago looked at 954 ... disability at the start of the study period. The participants ... their social activities, such as going out to eat, playing ...
... is a devastating experience. Still under the shock of the ... turn to for advice and treatment, with the possibility to ... a community oncology hospital. "When my oncologist informed ... (Plasmocytoma), I was disoriented. As a patient I was looking ...
... Minn. New research shows people who have used ... at an increased risk of developing Parkinson,s disease, according ... at the American Academy of Neurology,s 63rd Annual Meeting ... Benzedrine and Dexedrine are amphetamines often prescribed to ...
Cached Medicine News:Health News:Bone-Anchored Hearing Aids May Benefit Kids 2Health News:High Cholesterol, Hypertension May Harm Memory in Middle Age 2Health News:High Cholesterol, Hypertension May Harm Memory in Middle Age 3Health News:Busy Social Life May Stave Off Disability in Elderly 2Health News:Community oncology: Ensuring the best standards of care 2Health News:Community oncology: Ensuring the best standards of care 3Health News:Community oncology: Ensuring the best standards of care 4Health News:Using amphetamines may increase risk of Parkinson's disease 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: